Responses
Late-breaking abstracts
COVID and immunotherapy
826 Risk of COVID-19 infection among patients receiving immune checkpoint inhibitor therapy: a tertiary care hospital system collaboration with the Massachusetts department of health
Compose a Response to This Article
Other responses
No responses have been published for this article.